Insurance News & Info

CHICAGO (Reuters) – A potentially deadlier form of the bird flu virus poses one of the gravest known threats to humans and justifies an unprecedented call to censor the research that produced it, a top U.S. biosecurity official said on Tuesday. Th… View full post on Yahoo! Health News

CHICAGO (Reuters) – A potentially deadlier form of the bird flu virus poses one of the gravest known threats to humans and justifies an unprecedented call to censor the research that produced it, a top U.S. biosecurity official said on Tuesday. Th… View full post on Yahoo! Health News

TOKYO (Reuters) – An Olympus Corp panel plans to recommend the endoscope maker sue current and former executives for more than 90 billion yen ($1.2 billion) in scandal-related damages, and its president, Shuichi Takayama, is expected to resign by … View full post on Yahoo! Health News

The panel formed by Connecticut Gov. Dannel P. Malloy to review the preparations and responses by the state, utilities and others to the remnants of Hurricane Irene and the freak October snowstorm is wrapping up its work. Malloy said the … View full post on Insurance Journal » News

WASHINGTON (Reuters) – Dr. Ned Calonge knows firsthand how hard it is to tell Americans they'd be better off with fewer routine medical tests. A long-time family doctor in Colorado, Calonge presided over the U.S. Preventive Services Task Force… View full post on Yahoo! Health News

CHICAGO (Reuters) – Use of chimpanzees in government-funded medical research should be strictly limited, reserved only for studies where no suitable alternative is available or where testing in people would be unethical, a U.S. expert panel said o… View full post on Yahoo! Health News

U.S. drug advisers recommended approving an experimental treatment from Alexza Pharmaceuticals for calming down patients with schizophrenia or bipolar disorder, but placed restrictions on how the drug should be used. Advisers to the Food and Drug … View full post on Yahoo! Health News

A panel of federal health advisers said Friday that a birth control patch from Johnson & Johnson probably carries a higher risk of blood clots than older drugs, but should remain available as an option for women who have trouble taking a daily… View full post on Yahoo! Health News

Pfizer Inc won unanimous expert backing for its Inlyta experimental drug for patients with advanced kidney cancer. View full post on Yahoo! Health News

A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman. View full post on Yahoo! Health News